Role for IKK2 in muscle: Waste not, want not

Journal of Clinical Investigation

Volumn 116, Issue 11, 2006, Pages 2866-2868

  Karin, Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F BOX PROTEIN; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ALLELE; GENE DELETION; GENE EXPRESSION; MUSCLE ATROPHY; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; MUSCLE STRENGTH; MUSCLES; MUSCULAR DYSTROPHIES;

EID: 33750591642     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30268     Document Type: Review

References (24)

1. Barnes, P.J., and Karin, M. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071.
2. Ghosh, S., and Karin, M. 2002. Missing pieces in the NF-kB puzzle. Cell. 109(Suppl.):S81-S96.
3. Rothwarf, D.M., and Karin, M. 1999. The NF-kB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE. 1999:RE1.
4. Li, Q., and Verma, I.M. 2002. NF-kB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
5. Chen, L.W., et al. 2003. The two faces of IKK and NF-kB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9:575-581.
6. Greten, F.R., et al. 2004. IKKb links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 118:285-296.
7. Arkan, M.C., et al. 2005. IKKb links inflammation to obesity-induced insulin resistance. Nat. Med. 11:191-198.
8. Mourkioti, F., et al. 2006. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 116:2945-2954. doi:10.1172/JCI28721.
9. Nowak, K.J., and Davies, K.E. 2004. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep. 5:872-876.
10. Tisdale, M.J. 2002. Cachexia in cancer patients. Nat. Rev. Cancer. 2:862-871.
11. Dalakas, M.C. 2004. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr. Opin. Neurol. 17:561-567.
12. Cai, D., et al. 2004. IKKb/NF-kB activation causes severe muscle wasting in mice. Cell. 119:285-298.
13. Musaro, A., et al. 2001. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27:195-200.
14. Bodine, S.C., et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 294:1704-1708.
15. Stitt, T.N., et al. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell. 14:395-403.
16. Sandri, M., et al. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 117:399-412.
17. Karin, M., and Lin, A. 2002. NF-kB at the crossroads of life and death. Nat. Immunol. 3:221-227.
18. Chang, L., et al. 2006. The E3 ubiquitin ligase itch couples JNK activation to TNFa-induced cell death by inducing c-FLIP(L) turnover. Cell. 124:601-613.
19. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. 1996. Suppression of TNFa-induced apoptosis by NF-kB. Science. 274:787-789.
20. Kamata, H., et al. 2005. Reactive oxygen species promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 120:649-661.
21. Bonizzi, G., and Karin, M. 2004. The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288.
22. Karin, M., Yamamoto, Y., and Wang, Q.M. 2004. The IKK NF-kB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3:17-26.
23. Burke, J.R., et al. 2003. BMS-345541 is a highly selective inhibitor of IkB kinase that binds at an allosteric site of the enzyme and blocks NF-kB-dependent transcription in mice. J. Biol. Chem. 278:1450-1456.
24. Sharma, V., Lansdell, T.A., Peddibhotla, S., and Tepe, J.J. 2004. Sensitization of tumor cells toward chemotherapy: enhancing the efficacy of camptothecin with imidazolines. Chem. Biol. 11:1689-1699.